SCHEMBL4450103

SCHEMBL4450103

CN1C(=O)OC(C)(F)C1(F)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSD11B1 P28845 4/20 0.37
MMP2 P08253 2/20 0.35
MMP9 P14780 2/20 0.35
MMP3 P08254 1/20 0.35
ELANE P08246 1/20 0.35
CTSG P08311 1/20 0.35
PRTN3 P24158 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
DRD2 P14416 1/20 0.35
ALDH1A1 P00352 2/20 0.34
TP53 P04637 1/20 0.34
GRM2 Q14416 1/20 0.34
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4460824 0.83 GAA (0.42) GAAL3MBTL1HSD11B1MMP2MMP9
SCHEMBL4452493 0.81 MMP2 (0.41) GAAL3MBTL1HSD11B1MMP2MMP9
SCHEMBL4450100 0.76 HSD11B1 (0.37) HSD11B1MMP2MMP9MMP3ELANE
SCHEMBL4480093 0.73 ELANE (0.38) GAAL3MBTL1HSD11B1MMP2MMP9
SCHEMBL4452489 0.71 MMP2 (0.40) GAAL3MBTL1HSD11B1MMP2MMP9
SCHEMBL4454486 0.70 GAA (0.35) GAAL3MBTL1HSD11B1MMP2MMP9
SCHEMBL4454824 0.68 GRM2 (0.40) HSD11B1MMP2MMP9MMP3GRM2
SCHEMBL4458256 0.68 IDH1 (0.39) HSD11B1MMP2MMP9MMP3ALDH1A1
SCHEMBL4452501 0.64 FAAH (0.35) L3MBTL1HSD11B1MMP2MMP9MMP3
SCHEMBL4480090 0.64 HSD11B1 (0.36) HSD11B1MMP2MMP9MMP3ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 GAA 121/4885L3MBTL1 4751/4885HSD11B1 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.